This review compared surgical, expectant and medical management of first-trimester miscarriage. Surgical management was significantly more likely to induce complete evacuation of the uterus after miscarriage than medical management. The review was fairly well conducted, but the results should be interpreted with caution given the variable quality and differences between the included studies.
Data extraction
Two reviewers independently extracted the data and any disagreements were resolved through consensus. Authors were contacted where data were missing.
Methods of synthesis
How were the studies combined? A meta-analysis was used to estimate the pooled risk ratio and risk difference (RD), with 95% confidence intervals (CIs), using both fixed-effect and random-effects models. The results obtained using random-effects models were presented in the text. The authors also calculated the number-needed-to-treat (NNT). The following comparisons were made: medical versus expectant management, surgical versus expectant management, surgical versus medical management, and vaginal versus oral misoprostol. The authors stated that whilst they did not formally assess publication bias, they did consider the overall effectiveness of the largest trials in comparison with the results from the metaanalyses.
How were differences between studies investigated?
A chi-squared test was used to test statistical heterogeneity. Where possible, studies were split into subgroups: studies that included only cases of gestational age of 8 weeks or less, those that included only incomplete miscarriages, and those that reported success at 48 hours or more.
Results of the review
Twenty-seven trials (n=3,177) were included; the number of participants in each trial ranged from 20 to 611.
The authors reported that 3 studies were double-blind, 16 adequately described the method of randomisation, 15 adequately described allocation concealment and 26 adequately described withdrawals.
Seven studies compared medical with expectant management (n=513). Medical management was almost three times more likely than expectant management to induce complete evacuation of conception products (RD 49.7%, 95% CI: 28.3, 71.1, p<0.001) with an NNT of 2. However, there was significant heterogeneity between the studies (p<0.001).
Patient satisfaction could not be compared.
Five studies compared surgical with expectant management (n=545). There was no significant difference in complete evacuation of the uterine cavity between the two management strategies, although the results favoured surgical management (overall RD 16.2%, 95% CI: -2.5, 35.0, p=0.09). There was significant heterogeneity between the studies (p<0.001). Based on 2 studies with significant heterogeneity (p=0.02), there was no significant difference in the rate of patient satisfaction.
Nine studies compared surgical with medical management (n=1,376). Surgical management was more likely than medical management to induce complete evacuation of conception products (RD 32.8%, 95% CI: 14.4, 51.1; p<0.001) with an NNT of 3. However, there was significant heterogeneity between the studies (p<0.001). Patient satisfaction did not significantly differ between surgical and medical management.
Four studies compared vaginal with oral misoprostol (n=496). These medical treatments did not significantly differ in rates of successful treatment (RD 8.3%, CIs not reported, p=0.29). There was significant heterogeneity between the studies.
In addition, one study compared different doses of oral misoprostol, one compared misoprostol with dinoprostone, and one compared methotrexate plus misoprostol with misoprostol alone (overall n=247).
Subgroup analyses did not change directions of significance for any of the comparisons. No differences in major complications or adverse events were reported for any of the comparisons.
